LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is also pursuing the sale of its remaining pipeline assets.
Follow-Up Questions
LIANY hissesinin fiyat performansı nasıl?
LIANY 'in mevcut fiyatı $0.0543 'dir, son işlem günde 0% decreased etti.
LianBio için ana iş temaları veya sektörler nelerdir?
LianBio Biotechnology endüstrisine ait ve sektör Health Care 'dir